MRVI Earnings

Quarterly EPS
$-0.68
Q3 2024
$-0.18
Q4 2024
$-0.21
Q1 2025
$-0.27
Q2 2025
$-0.18
Q3 2025
$-0.25
Q4 2025
$-0.02
Q1 2026
$-0.08
Q2 2026
Latest Revenue51.4M
Latest Net Income-21631000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.0851.4M-21631000+8.5%+70.4%
Q1 2026-$0.0265.8M-6377000+40.5%+90.5%
Q4 2025-$0.2549.9M-63015000-11.8%-38.9%
Q3 2025-$0.1841.6M-45057000-39.7%+73.5%
Q2 2025-$0.2747.4M-69837000-31.7%-285.7%
Q1 2025-$0.2146.9M-52853000-27.0%-133.3%
Q4 2024-$0.1856.6M-46067000-23.7%+77.5%
Q3 2024-$0.6869.0M-172455000+3.2%-1,260.0%
Q2 2024-$0.0769.4M-18420000
Q1 2024-$0.0964.2M-22680000
Q4 2023-$0.8074.1M-109982000
Q3 2023-$0.0566.9M-15102000
Maravai LifeSciences (MRVI) — Earnings